[go: up one dir, main page]

ZA200703996B - Indoline compound and process for producing the same - Google Patents

Indoline compound and process for producing the same

Info

Publication number
ZA200703996B
ZA200703996B ZA200703996A ZA200703996A ZA200703996B ZA 200703996 B ZA200703996 B ZA 200703996B ZA 200703996 A ZA200703996 A ZA 200703996A ZA 200703996 A ZA200703996 A ZA 200703996A ZA 200703996 B ZA200703996 B ZA 200703996B
Authority
ZA
South Africa
Prior art keywords
propyl
same
phenoxy
dihydro
producing
Prior art date
Application number
ZA200703996A
Other languages
English (en)
Inventor
Yamaguchi Toshiaki
Tsuchiya Ikuo
Kikuchi Ken
Yanagi Takashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ZA200703996B publication Critical patent/ZA200703996B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200703996A 2004-10-27 2005-10-24 Indoline compound and process for producing the same ZA200703996B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004313040 2004-10-27

Publications (1)

Publication Number Publication Date
ZA200703996B true ZA200703996B (en) 2008-09-25

Family

ID=36227738

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703996A ZA200703996B (en) 2004-10-27 2005-10-24 Indoline compound and process for producing the same

Country Status (17)

Country Link
US (1) US7834193B2 (fr)
EP (1) EP1806340B1 (fr)
JP (1) JP5049013B2 (fr)
KR (1) KR101249865B1 (fr)
CN (1) CN101048376B (fr)
AT (1) ATE508113T1 (fr)
AU (1) AU2005298078B2 (fr)
BR (1) BRPI0517515B8 (fr)
CA (1) CA2583660C (fr)
DE (1) DE602005027881D1 (fr)
ES (1) ES2362788T3 (fr)
IL (1) IL182642A (fr)
MX (1) MX2007005126A (fr)
RU (1) RU2379289C2 (fr)
TW (1) TW200621709A (fr)
WO (1) WO2006046499A1 (fr)
ZA (1) ZA200703996B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
WO2008106125A2 (fr) 2007-02-26 2008-09-04 Concert Pharmaceuticals, Inc. Antagonistes du récepteur alpha 1a-adrénergique
WO2008106536A1 (fr) * 2007-02-28 2008-09-04 Kissei Pharmaceuticals Co., Ltd. Utilisation de silodosine administrée une fois par jour pour le traitement d'une hyperplasie prostatique bénigne
CN101585798B (zh) * 2008-05-20 2011-06-15 浙江华海药业股份有限公司 光学活性化合物1-(3-苯甲酰氧基丙基)-5-(2-(1-苯基乙基胺)丙基)-7-氰基吲哚啉及其制备方法和用途
CN101993406B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 光学活性的吲哚啉化合物及其制备方法
CN101993405B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 吲哚啉衍生物、及其制备方法和用途
CN101993407B (zh) * 2009-08-27 2014-01-29 浙江华海药业股份有限公司 用于制备西洛多辛的吲哚啉化合物及其制备方法
EP2475634B1 (fr) * 2009-09-12 2017-05-24 Sandoz AG Procédé pour la préparation de dérivés d'indoline et leurs intermédiaires
CN101768056B (zh) * 2010-01-19 2013-10-16 扬子江药业集团有限公司 一种取代的苯基甲基醚的制备方法
WO2011101864A1 (fr) 2010-02-17 2011-08-25 Panacea Biotec Ltd Nouveau procédé de synthèse de dérivés de phénoxyéthyle
WO2011124704A1 (fr) 2010-04-09 2011-10-13 Ratiopharm Gmbh Procédé de préparation d'un intermédiaire pour la silodosine
CN102311319A (zh) * 2010-07-05 2012-01-11 浙江华海药业股份有限公司 一种制备2-(2,2,2-三氟乙基)苯甲醚的方法
WO2012014186A1 (fr) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Procédé de préparation de silodosin et de nouveaux intermédiaires de celui-ci
CN102229558B (zh) * 2010-08-05 2013-05-08 南京海纳医药科技有限公司 西洛多辛的晶型δ、它的制备方法和包含它的药物组合物
CN102229557B (zh) * 2010-08-05 2013-03-27 南京海纳医药科技有限公司 西洛多辛的半水合物晶体、制备方法和包含它的药物组合物
WO2012062229A1 (fr) 2010-11-12 2012-05-18 Zentiva, K.S. Procédé de fabrication du composé (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroéthoxy)-phénoxyéthyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide
CZ2010837A3 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
CZ2010836A3 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
WO2012131710A2 (fr) 2011-03-30 2012-10-04 Panacea Biotec Ltd Nouveau procédé pour la synthèse de dérivés d'indoline
WO2012147019A1 (fr) * 2011-04-26 2012-11-01 Orchid Chemicals And Pharamceuticals Limited Procédé amélioré de préparation de la silodosine
WO2012147107A2 (fr) * 2011-04-29 2012-11-01 Msn Laboratories Limited Nouveaux procédés améliorés destinés à la préparation de dérivés d'indoline et composition pharmaceutique associée
CN102382029B (zh) * 2011-07-26 2016-06-29 浙江华海药业股份有限公司 一种西洛多辛中间体成盐制备方法
WO2013072935A2 (fr) 2011-10-10 2013-05-23 Cadila Healthcare Limited Procédé de préparation du silodosin
US20150038727A1 (en) 2011-10-21 2015-02-05 Sandoz Ag Method for preparing silodosin
CN102675182B (zh) * 2012-05-24 2014-03-26 临海天宇药业有限公司 1-(3-苯甲酰氧基丙基)-5-(2-羰基丙基)-7-腈基吲哚啉的制备方法
WO2014118606A2 (fr) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited Nouveau procédé de préparation de silodosine
CN103159664B (zh) * 2013-03-29 2016-03-23 深圳市海滨制药有限公司 一种赛洛多辛原料药及其制备方法、药物组合物
CN104140389A (zh) * 2013-05-06 2014-11-12 昆明积大制药股份有限公司 一种赛洛多辛及其中间体的制备方法
CN103420893B (zh) * 2013-08-02 2015-11-25 江苏和成新材料有限公司 制备西洛多辛中间体的方法
EP3103794A4 (fr) * 2014-02-06 2017-10-04 UBE Industries, Ltd. Procédé de production d'un composé indoline
KR20150098565A (ko) * 2014-02-20 2015-08-28 한미정밀화학주식회사 실로도신 제조에 사용되는 신규 중간체, 이의 제조방법 및 이를 이용한 실로도신의 제조방법
KR20150127996A (ko) * 2014-05-08 2015-11-18 한미정밀화학주식회사 실로도신 감마형 결정의 제조방법
JP6242298B2 (ja) * 2014-06-13 2017-12-06 株式会社トクヤマ １−（３−ベンゾイルオキシプロピル）−７−シアノ−５−［（２ｒ）−２−（｛２−［２−（２，２，２−トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］インドリンまたはその塩を製造する方法
KR101628946B1 (ko) * 2014-07-09 2016-06-09 동방에프티엘(주) 실로도신의 개선된 제조방법
KR101725393B1 (ko) 2014-07-24 2017-04-27 주식회사 경보제약 실로도신의 제조 방법 및 신규 중간체
WO2016042441A1 (fr) 2014-09-18 2016-03-24 Mankind Research Centre Nouveau procédé de préparation de silodosine largement pure
JP2016088847A (ja) * 2014-10-30 2016-05-23 株式会社トクヤマ （‐）‐１‐（３‐ヒドロキシプロピル）‐５‐［［（２ｒ）‐２‐（｛２‐［２‐（２，２，２‐トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］‐２，３‐ジヒドロ‐１ｈ‐インドール‐７‐カルボキサミド］）の製造方法
CN104478784B (zh) * 2014-11-17 2017-02-22 武汉工程大学 一种西洛多辛草酸盐的晶型及其制备方法
KR101694262B1 (ko) * 2014-12-18 2017-01-10 (주)다산메디켐 실로도신의 결정형의 제조방법
US9356405B1 (en) 2015-03-05 2016-05-31 Sony Corporation Connector tongue element for an electrical connector plug receptacle and a method for producing the same
US10457668B2 (en) 2015-09-23 2019-10-29 Biocon Limited Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posaconazole
AU2016327159A1 (en) * 2015-09-23 2018-04-26 Biocon Limited The process of preparing indoline compounds and a novel indoline salt
ES2607639B1 (es) * 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina
CN106995399A (zh) * 2016-01-25 2017-08-01 北京天泰恒华医药技术有限公司 一种制备赛洛多辛的方法
KR102365411B1 (ko) * 2017-08-08 2022-02-21 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법
KR102163068B1 (ko) * 2018-07-04 2020-10-07 주식회사 가피바이오 실로도신 합성용 중간체의 제조 방법 및 이를 이용한 실로도신의 제조 방법
CN111217735B (zh) * 2018-11-27 2023-03-14 上海汇伦医药股份有限公司 赛洛多辛中间体的制备方法
WO2020237645A1 (fr) * 2019-05-31 2020-12-03 上海汇伦生命科技有限公司 Procédé de préparation d'intermédiaire de silodosine
CN110452149B (zh) * 2019-06-13 2021-11-02 北京鑫开元医药科技有限公司 二氢吲哚化合物的制备方法、二氢吲哚化合物及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
EP0600675B1 (fr) 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Composés indoliniques pour le traitement de la dysurien
TW281669B (fr) * 1993-02-17 1996-07-21 Chugai Pharmaceutical Co Ltd
JP3331047B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドリン誘導体
JP2526811B2 (ja) * 1994-07-22 1996-08-21 田辺製薬株式会社 フェネチルアミン誘導体及びその製法
ATE264841T1 (de) * 1998-02-27 2004-05-15 Kissei Pharmaceutical Indol-derivate und medizinische zusammensetzungen die diese enthalten
JP4634560B2 (ja) * 2000-01-14 2011-02-16 キッセイ薬品工業株式会社 光学活性なインドリン誘導体の製造方法およびその製造中間体
JP4921646B2 (ja) * 2001-03-08 2012-04-25 キッセイ薬品工業株式会社 １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法
JP2006188470A (ja) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd インドリン誘導体およびその製造方法

Also Published As

Publication number Publication date
IL182642A0 (en) 2007-07-24
BRPI0517515A (pt) 2008-10-14
AU2005298078B2 (en) 2011-03-31
IL182642A (en) 2012-10-31
JP5049013B2 (ja) 2012-10-17
CN101048376A (zh) 2007-10-03
RU2379289C2 (ru) 2010-01-20
AU2005298078A1 (en) 2006-05-04
BRPI0517515B8 (pt) 2021-05-25
TW200621709A (en) 2006-07-01
US7834193B2 (en) 2010-11-16
EP1806340B1 (fr) 2011-05-04
RU2007115888A (ru) 2008-11-10
CA2583660C (fr) 2013-02-12
CA2583660A1 (fr) 2006-05-04
HK1113364A1 (en) 2008-10-03
BRPI0517515B1 (pt) 2021-03-09
EP1806340A1 (fr) 2007-07-11
KR20070084499A (ko) 2007-08-24
CN101048376B (zh) 2011-03-23
ES2362788T3 (es) 2011-07-13
JPWO2006046499A1 (ja) 2008-05-22
WO2006046499A1 (fr) 2006-05-04
EP1806340A4 (fr) 2009-08-12
US20070197627A1 (en) 2007-08-23
ATE508113T1 (de) 2011-05-15
KR101249865B1 (ko) 2013-04-02
TWI356819B (fr) 2012-01-21
MX2007005126A (es) 2007-07-04
DE602005027881D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
IL182642A0 (en) Indoline compound and process for producing the same
CN1280266C (zh) 酰基苯基脲衍生物,其制备方法和作为药物的用途
CN1234705C (zh) 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法
CN1285578C (zh) 取代苯甲酸酰胺及其在抑制血管生成中的应用
CN1246287C (zh) 联萘酚衍生物及其制备方法
JP3034819B2 (ja) １，２−ジフェニルピロール誘導体及び医薬組成物
ES2524916T3 (es) Compuestos heterocíclicos de ácido borónico
EP2412706B1 (fr) Nouveau dérivé hydroxamate, procédé de production associé, et composition pharmaceutique comprenant le dérivé
RU2005108668A (ru) Индолы, обладающие противодиабетической активностью
JP2006519874A (ja) ジフェニルエチレン化合物およびその使用
CN1522246A (zh) 作为微粒体甘油三酯转移蛋白(mtp)和/或载脂蛋白b(apo b)分泌抑制剂的三酰胺取代的吲哚、苯并呋喃及苯并噻吩
RU2005118409A (ru) Новые гидроксииндолы, их применение в качестве ингибиторов фосфодиэстеразы 4 и способ их получения
KR20110099027A (ko) 암 및 면역 질환 및 자가면역 질환의 치료를 위한 아폽토시스-유도제
CN1411440A (zh) 含有3－氨基氮杂环丁烷衍生物的药物组合物,新型衍生物及其制备方法
CN106397418A (zh) 治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导剂
CN106536479B (zh) 用于制备β-氨基砜化合物的方法
CN1221734A (zh) 新的萘化合物、其制备方法及其药物组合物
CN1095836C (zh) 苯并咪唑衍生物
CN1276783A (zh) 2－苯氧基苯胺衍生物
CN1533378A (zh) 制备喹唑啉的方法
CN1413215A (zh) 吡唑并哒嗪衍生物的制备方法
CN101074208A (zh) 吲哚衍生物的制备方法
CN1361773A (zh) 取代的3－吡啶基－4－芳基吡咯及治疗和预防相关疾病的方法
CN1432013A (zh) 咪唑衍生物或其盐以及含有该衍生物或其盐的药物
Grünstein et al. Enantioselective synthesis and biological investigation of tetrahydro‐β‐carboline‐based HDAC6 inhibitors with improved solubility